Biology subjects

Gleave, E. J.

Publications and source records attributed to Gleave, E. J..

2 recordsLinked to original sources

bioRxiv2025

Evaluation of Deep Learning Algorithms to Predict Multiple Dementia-Related Neuropathologies from Brain MRI, Clinical and Genetic Data

Alzheimers disease and related dementias (ADRD) involve overlapping neurodegenerative and vascular pathologies--such as amyloid-{beta} (A{beta}), tau, cerebral amyloid angiopathy (CAA), TDP-43, and alpha-synuclein--that complicate diagnosis and treatment. While PET and CSF biomarkers are useful for detecting A{beta} and tau, they are invasive, expensive, and not widely available. In contrast, magnetic resonance imaging (MRI) is non-invasive and widely accessible, offering an opportunity for pathology prediction when combined with deep learning. Most prior studies have focused on single-pathology detection, but there remains a need for models that can jointly predict multiple co-occurring pathologies. In this work, we evaluate deep learning models that integrate structural MRI with demographic, clinical, and genetic data to classify six autopsy-confirmed neuropathologies: A{beta}, tau, CAA, TDP-43, hippocampal sclerosis, and dementia with Lewy bodies. We compare our hybrid deep learning model to AutoGluon, an automated machine learning framework. Our findings support the potential of multimodal AI to enable non-invasive, comprehensive neuropathological profiling in ADRD.

neuroscience↗

bioRxiv2025

Deep Learning to Predict Future Cognitive Decline: A Multimodal Approach Using Brain MRI and Clinical Data

Predicting the trajectory of clinical decline in aging individuals is a pressing challenge, especially for people with mild cognitive impairment, Alzheimers disease, Parkinsons disease, or vascular dementia. Accurate predictions can guide treatment decisions, identify risk factors, and optimize clinical trials. In this study, we compared two deep learning approaches for forecasting changes, over a 2-year interval, in the Clinical Dementia Rating scale sum of boxes score (sobCDR). This is a key metric in dementia research, and scores range from 0 (no impairment) to 18 (severe impairment). To predict decline, we trained a hybrid convolutional neural network that integrates 3D T1-weighted brain MRI scans with tabular clinical and demographic features (including age, sex, body mass index (BMI), and baseline sobCDR). We benchmarked its performance against AutoGluon, an automated multimodal machine learning framework that selects an appropriate neural network architecture. Our results demonstrate the importance of combining image and tabular data in predictive modeling for clinical applications. Deep learning algorithms can fuse image-based brain signatures and tabular clinical data, with potential for personalized prognostics in aging and dementia.

neuroscience↗